Hubert Niemyjski, country manager of Coloplast Poland and the Baltics, highlights the large differences between the market landscape of the company’s three pillars; ostomy, wound and continence care. Additionally, he discusses the importance of taking into consideration QOL when making reimbursement decisions and the amazing potential of the Polish market for Coloplast if a more holistic approach is taken.
How has the transition been coming from the world of pharmaceuticals to medical devices?
"Nurses education is a priority as they will improve the overall care of affected Poles and this is our major focus."
